Skip to main content

Antibiotics Topic Center

Featured Article

News
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
From Veterans Health Today
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network
News
02/26/2021
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling...
02/26/2021
Pharmacy Learning Network
News
01/04/2021
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows...
01/04/2021
Pharmacy Learning Network
News
06/03/2020
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for...
06/03/2020
Pharmacy Learning Network
News
03/27/2020
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used...
03/27/2020
Pharmacy Learning Network
News
02/21/2020
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of...
02/21/2020
Pharmacy Learning Network
News
02/03/2020
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend...
02/03/2020
Pharmacy Learning Network

Newsfeed

News
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
News
10/22/2019
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial...
10/22/2019
Pharmacy Learning Network
News
05/01/2019
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings,...
05/01/2019
Pharmacy Learning Network
News
03/07/2019
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions...
03/07/2019
Pharmacy Learning Network
News
05/11/2018
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk...
05/11/2018
Pharmacy Learning Network
News
04/05/2018
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over...
04/05/2018
Pharmacy Learning Network
PharmLaw
04/29/2026
Grace Taylor, MS, MA
Purdue Pharma’s federal sentencing finalizes a landmark opioid case involving fraud and kickback conspiracies, with lasting compliance implications for the pharmaceutical supply chain.
Purdue Pharma’s federal sentencing finalizes a landmark opioid case involving fraud and kickback conspiracies, with lasting compliance implications for the pharmaceutical supply chain.
Purdue Pharma’s federal...
04/29/2026
Pharmacy Learning Network
News
04/23/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for memantine hydrochloride capsules due to failure to meet dissolution specifications.
The US Food and Drug Administration (FDA) has issued a Class II recall for memantine hydrochloride capsules due to failure to meet dissolution specifications.
The US Food and Drug...
04/23/2026
Pharmacy Learning Network
News
04/23/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for semaglutide-glycine-cyanocobalamin injectable due to sterility assurance concerns, affecting 91 units.
The US Food and Drug Administration (FDA) has issued a Class II recall for semaglutide-glycine-cyanocobalamin injectable due to sterility assurance concerns, affecting 91 units.
The US Food and Drug...
04/23/2026
Pharmacy Learning Network
News
04/23/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Essential Calming Skin Gel due to subpotent drug, affecting nearly 300 units.
The US Food and Drug Administration (FDA) has issued a Class III recall for Essential Calming Skin Gel due to subpotent drug, affecting nearly 300 units.
The US Food and Drug...
04/23/2026
Pharmacy Learning Network
PharmLaw
04/21/2026
Hannah Musick
A new executive order directs federal agencies to accelerate the development, review, and potential patient access to investigational psychedelic therapies for serious mental illness, signaling a shift in regulatory and research priorities...
A new executive order directs federal agencies to accelerate the development, review, and potential patient access to investigational psychedelic therapies for serious mental illness, signaling a shift in regulatory and research priorities...
A new executive order directs...
04/21/2026
Pharmacy Learning Network
News
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for epinephrine injection due to sterility assurance concerns, affecting more than 80 000 units used in emergency care settings.
The US Food and Drug Administration (FDA) has issued a Class II recall for epinephrine injection due to sterility assurance concerns, affecting more than 80 000 units used in emergency care settings.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Cipla’s cinacalcet tablets due to nitrosamine impurity levels exceeding safety limits, raising concerns for long-term use in dialysis patients.
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Cipla’s cinacalcet tablets due to nitrosamine impurity levels exceeding safety limits, raising concerns for long-term use in dialysis patients.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
PharmLaw
04/15/2026
Hannah Musick
The Centers for Medicare & Medicaid Services has proposed sweeping reforms to modernize prior authorization for drugs, introducing faster decision timelines, expanded electronic requirements, and new transparency measures that could...
The Centers for Medicare & Medicaid Services has proposed sweeping reforms to modernize prior authorization for drugs, introducing faster decision timelines, expanded electronic requirements, and new transparency measures that could...
The Centers for Medicare &...
04/15/2026
Pharmacy Learning Network
News
04/09/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Xanax XR tablets after testing revealed failed dissolution specifications, potentially affecting consistent drug release in patients treated for panic disorder.
The US Food and Drug Administration (FDA) has issued a Class II recall for Xanax XR tablets after testing revealed failed dissolution specifications, potentially affecting consistent drug release in patients treated for panic disorder.
The US Food and Drug...
04/09/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network

Interactive Features